QUALITY OF LIFE OF ASYMPTOMATIC MEN WITH NONMETASTATIC PROSTATE CANCER ON ANDROGEN DEPRIVATION THERAPY
- 1 June 2000
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
- Vol. 164 (6), 1743-1746
- https://doi.org/10.1097/00005392-200006000-00025
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Bicalutamide Monotherapy Versus Flutamide Plus Goserelin in Prostate Cancer Patients: Results of an Italian Prostate Cancer Project StudyJournal of Clinical Oncology, 1999
- DEFERRED TREATMENT OF LOCALLY ADVANCED NONMETASTATIC PROSTATE CANCER: A LONG-TERM FOLLOWUPJournal of Urology, 1999
- Quality of Life in Advanced Prostate Cancer: Results of a Randomized Therapeutic TrialJNCI Journal of the National Cancer Institute, 1998
- ANDROGEN DEPRIVATION THERAPY FOR ASYMPTOMATIC ADVANCED PROSTATE CANCER IN THE PROSTATE SPECIFIC ANTIGEN ERA: A NATIONAL SURVEY OF UROLOGIST BELIEFS AND PRACTICESJournal of Urology, 1998
- Testosterone and FrailtyClinics in Geriatric Medicine, 1997
- Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trialBritish Journal of Urology, 1997
- The inhibitory effect of testosterone on hypothalamic-pituitary-adrenal responses to stress is mediated by the medial preoptic areaJournal of Neuroscience, 1996
- Quality-of-Life Outcomes in Men Treated for Localized Prostate CancerJAMA, 1995
- Quality of life of patients with prostate cancer and their spouses. The value of a data base in clinical careCancer, 1994
- A comparison of the quality of life of patients with metastatic prostate cancer who received or did not receive hormonal therapyCancer, 1993